PSEN1 and Anxiety: Notably, patients in prodromal phases of AD show memory impairments [59, 62], depression [6, 54, 55], anxiety [55] and reduction of olfaction function [61], as we observed in APP/PSEN1-Tg mice at 3 and 6 months of age.